Linden Capital Partners, a Chicago-based private equity firm focused exclusively on the healthcare industry, has signed a definitive agreement to make a majority investment in Aspirion.
Aspirion is a leading healthcare RCM provider across complex claims and revenue integrity, offering a broad array of technology-driven solutions for the most specialized revenue cycle challenges faced by hospital systems and healthcare providers.
The Company’s team of healthcare, legal, and technical professionals, in conjunction with its proprietary AI-enabled software, help hospitals and physicians improve claims processing time and increase overall collections. Aspirion’s product suite is centered on complex claims, an umbrella category for third party liability claims related to non-traditional payors, and revenue integrity, which addresses clinically complex claims with traditional medical payors.
Following the transaction, the Company’s management team and Aquiline Capital Partners, a private investment firm based in New York and London, will remain investors in the Company.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
“We are very excited to enter into this partnership with Linden and leverage Linden’s deep healthcare experience, relationships, and strategic support to execute against our shared value creation plan and better serve our clients,” said Jason Erdell, CEO of Aspirion.
Kam Shah, Partner at Linden, said “We congratulate Jason and the entire Aspirion management team on their collective roles in building a highly regarded provider of specialized RCM solutions whose differentiated capabilities help hospital systems and providers navigate a difficult operating environment characterized by increasing denial rates and growing complexity in patient clinical records. We look forward to supporting Aspirion and positioning the Company for continued growth, particularly through strategic investments in technology, product, and M&A.”
“We are proud to have helped Aspirion create its industry-leading complex claims RCM platform through investing in people, technology and strategic acquisitions,” said Jeff Greenberg, Chairman and CEO of Aquiline Capital Partners. “We look forward to continuing as investors and, alongside Linden, supporting Aspirion through its planned next phase of growth.”
The transaction is subject to customary closing conditions. Baird is serving as exclusive financial advisor and Ropes & Gray LLP is serving as legal counsel to Aquiline and Aspirion. Guggenheim Securities, LLC and Cain Brothers, a division of KeyBanc Capital Markets Inc., are serving as financial advisors and Kirkland & Ellis LLP is serving as legal counsel to Linden. Twin Brook Capital Partners is providing debt financing for the transaction.
Source: PR Newswire
Can’t stop reading? Read more
I Squared Weighs Stake Sale in $1bn India’s Think Gas
I Squared Capital is considering selling a minority stake in Think Gas Distribution Pvt. that...
Ares Faces Its Biggest Decision Yet: Stick With Private Credit or Become an Alts Supermarket
Ares Management Corp. faces the sort of quandary that other financial firms might find enviable....
What Does Private Equity See in Football?
It’s easy to understand why super-wealthy individuals or oil-rich nations might want to buy...